In Brief: Columbia Labs
This article was originally published in The Tan Sheet
Executive Summary
Columbia Labs: Acquires worldwide rights to a protein-based, bioadhesive technology for application in women's health care from French professor and researcher, Jean-Marc Aiche. Columbia says the natural protein is a complement to its own bioadhesive delivery system used in the Advantage/24 gel contraceptive "and enhances the company's ability to further expand its portfolio of unique products in women's health care"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning